In Body Hacking we explore the personalised medicine movement that’s revolutionising healthcare, and focus on the scientist-entrepreneurs who are reinventing medicine from their bedrooms, garages and employers’ laboratories.

The falling cost of genome sequencing, where our DNA is digitally profiled, suggests the existing ‘one size fits all’ approach to medical diagnosis and treatment could soon be consigned to the past. From pocket-sized kits that sample human DNA, microchip implants that keep tabs on our internal organs or assess our moods, and 3D printers that produce tailored hip replacements, the medical innovations of the ‘body hacking’ movement are beginning to filter into mainstream use.

Yet should we be concerned that individuals and private companies will increasingly be able to access our detailed genetic data? Might this information be used against us? And can the global biohacking movement really unsettle the dominance of the world’s corporate pharmaceutical giants?

Searching for answers we travelled to the City of London headquarters of IPGroup, a venture capital firm who fund some of the UK’s most exciting medical startups. We meet Mark Warne, their Head of Life Sciences, and discuss how the innovations of the Body Hacking movement are being seen on the high street and in the treatment rooms of your local GP.

We also meet Miguel Toribio-Mateas, the  founder of the personalised nutrition company Naturopatica, who explains how personalised medicine is complicated by epigenetics and nutrigenomics and also why the heightened awareness of our health risks a mass outbreak of hypochondria.